Statistics for CCL26-targeted siRNA treatment of alveolar type II cells decreases expression of CCR3-binding chemokines and reduces eosinophil migration: implications in asthma therapy

Total visits

views
CCL26-targeted siRNA treatment of alveolar type II cells decreases expression of CCR3-binding chemokines and reduces eosinophil migration: implications in asthma therapy 0

Total visits per month

views
October 2024 0
November 2024 0
December 2024 0
January 2025 0
February 2025 0
March 2025 0
April 2025 0

File Visits

views
Abonyo_CCL26-targeted siRNA treatment of alveolar type II cells decreases expression_compressed.pdf 4
Abonyo_CCL26-targeted siRNA treatment of alveolar type II cells decreases expression of CCR3-binding chemokines and reduces eosinophil migration implications in asthma therapy.pdf.pdf 2
Abonyo_CCL26-targeted siRNA treatment of alveolar type II cells decreases expression.pdf 1